Researchers used data from the National Survey on Drug Use and Health (2022 to 2023) to estimate racial and ethnic differences in mental health service.
News
Investigators examined the cardiovascular-kidney effects and safety of empagliflozin in a secondary analysis of a multicenter, clinical trial.
In a longitudinal study, researchers assessed the association between long-term ultraprocessed food consumption and nonmotor features suggestive of prodromal Parkinson disease.
Researchers analyzed data from a nationwide longitudinal study of adolescent children examining the relationship between ADHD symptom severity and sleep disruption.
Researchers used the US Mortality Database to assess the relationship between hypothyroidism and Alzheimer disease mortality.
A study was conducted to determine the relationship between polysubstance use and stroke risk in unstably housed women.
Researchers examined the diagnostic accuracy, interrater reliability, and safety of brain CT perfusion and CT angiography as ancillary investigations for DNC in a prospective, multicenter cohort study.
Investigators conducted a cross-sectional study to examine the influence of cognitive impairment risk factors on cognition and how BAG mediates this relationship.
Researchers conducted a meta-analytic synthesis of the literature on the association between paternal perinatal depression, anxiety, and stress and offspring development during the first 18 years of life.
Researchers examined the association between early-onset neonatal infection and ADHD and ASD in a nationwide register-based cohort study.
Researchers conducted a prospective study involving 31 patients who underwent MRI to examine the effectiveness of delayed postgadolinium 3-dimensional sampling perfection with application-optimized contrasts using different flip angle evolution fluid-attenuated inversion recovery sequence to differentiate between MD and VM.
Investigators conducted a cross-sectional study involving 144 children aged 5 to 8 years with nocturnal enuresis.
Researchers conducted a retrospective study using the MARINER165 national administrative database to examine the impact of SDoH on the prognosis and clinical outcomes of patients with ICH.
Researchers included data from the 2021-2022 Behavioral Risk Factor Surveillance System to examine 6 modifiable risk factors for cognitive decline: obesity, diabetes, poor sleep, smoking, hypertension, and physical inactivity.
Investigators examined the relationship between tinnitus and cognitive impairment using the National Health and Nutrition Examination Survey database.
Researchers compared the risk for psychiatric disorders among patients treated with GLP-1 RAs vs MBS during a 5-year follow-up in a retrospective cohort analysis.
In a retrospective review, researchers assessed the effect of galcanezumab exposure during pregnancy on maternal and fetal outcomes and compared these outcomes to those seen with placebo.
In a single-center, randomized, staggered-start, open-label clinical trial, researchers evaluated rimegepant for short-term prevention of fasting-related headache in adults fasting during Ramadan.
In a network meta-analysis of data from the CHALLENGE-MIG trial, researchers evaluated the relative efficacy and safety of atogepant compared with rimegepant and galcanezumab for the preventive treatment of episodic migraine.
In a small retrospective review, researchers assessed safety and efficacy of CGRP-targeted vs propranolol/metoprolol therapies in patients with both dysautonomia and headache disorders.
In a post hoc analysis, researchers examined the association between atogepant use and weight loss in patients with overweight or obesity receiving treatment for episodic or chronic migraine.
Using data from the ASCEND trial, researchers determined the effect of STS101 on cardinal symptoms of migraine.
In a post hoc REVIEW study analysis, researchers compared self-reported outcomes by level of improvement in good days/month with eptinezumab.
In the phase 3 EMERGE trial, researchers evaluated the efficacy and safety of meloxicam and rizatriptan in patients with migraine undergoing treatment with gepant for less than a month and experiencing an inadequate response.
In a post hoc subgroup analysis of a phase 3 randomized, double-blind, sham-controlled clinical trial, researchers examined whether patients with migraine with vs without aura respond differently to a 2-hour eTNS treatment, using data from the TEAM study.
In a retrospective chart review, researchers assessed the prevalence of normal vs abnormal brain MRI findings in pediatric patients diagnosed with migraine.
In a retrospective analysis, researchers assessed the effect of CoQ10 supplementation in pediatric patients diagnosed with new daily persistent headache.
In a phase 3, randomized, double-blind, placebo-controlled study, researchers assessed the safety and efficacy of fremanezumab for the prevention of headaches due to migraine in children and adolescents with episodic migraine.
Researchers describe development and validation of the HDDMS score, which is a composite score for measuring motor progression of HD in clinical research.
Investigators examined the independent and combined efficacy of MI and tDCS to attenuate reactivity to scenarios that can trigger UUI and to reduce UUI symptomatology.
